The Raiders have long had a reputation for prioritizing community involvement. This week is a perfect example of that. The ...

And now this month's news that BNY Mellon's Pershing will be debuting its own client referral program for RIAs as yet another ...

Lineage’s COR1 targets restoration of endothelial pump function via intracameral delivery and adhesion to Descemet membrane, ...

An AI tool helped to catch a woman's cancer before a human eye could notice it, while another program could help to change ...

PCWorld demonstrates how OpenAI’s Codex can generate a complete personal homepage in just 56 seconds using simple prompts and ...

Researchers find that muscular strength, as measured with two simple tests and independent of aerobic exercise, is a key ...

BIO-Europe Spring 2026 brought together more than 3,700 innovators in the life sciences industry all under the same roof.

Good morning, and welcome to Ocugen's Webcast to discuss the Top Line 12-month Results from Phase II ArMaDa Clinical Trial Evaluating OCU410 for Geographic Atrophy or GA Secondary to Dry Age-related ...

Aging does not arrive all at once. It builds quietly across years, touching cells long before symptoms appear. Scientists ...

It's my pleasure to be moderating this chat with the CEO of Voyager Therapeutics, Al Sandrock, who sure many folks know well from his current role and famous roles as prior. Al, maybe we can get into ...

Collaboration supports IND-enabling development and a planned Phase 1/2a first-in-human clinical study in type 1 diabetes ...